Saiyang Xie

471 total citations
18 papers, 299 citations indexed

About

Saiyang Xie is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Saiyang Xie has authored 18 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Saiyang Xie's work include Cardiac Fibrosis and Remodeling (8 papers), Inflammasome and immune disorders (3 papers) and Signaling Pathways in Disease (3 papers). Saiyang Xie is often cited by papers focused on Cardiac Fibrosis and Remodeling (8 papers), Inflammasome and immune disorders (3 papers) and Signaling Pathways in Disease (3 papers). Saiyang Xie collaborates with scholars based in China and United States. Saiyang Xie's co-authors include Wei Deng, Qizhu Tang, Yun Xing, Wei Deng, Qingqing Wu, Yuan Yuan, Zhulan Cai, Xiaofeng Zeng, Mingxia Duan and Shiqiang Liu and has published in prestigious journals such as Circulation, Cardiovascular Research and European Journal of Pharmacology.

In The Last Decade

Saiyang Xie

17 papers receiving 298 citations

Peers

Saiyang Xie
Muyin Liu China
Jin Wei China
Sherin Saheera United States
Muyin Liu China
Saiyang Xie
Citations per year, relative to Saiyang Xie Saiyang Xie (= 1×) peers Muyin Liu

Countries citing papers authored by Saiyang Xie

Since Specialization
Citations

This map shows the geographic impact of Saiyang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saiyang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saiyang Xie more than expected).

Fields of papers citing papers by Saiyang Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saiyang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saiyang Xie. The network helps show where Saiyang Xie may publish in the future.

Co-authorship network of co-authors of Saiyang Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Saiyang Xie. A scholar is included among the top collaborators of Saiyang Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saiyang Xie. Saiyang Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Lanlan, X. H. Mo, Yun Xing, et al.. (2025). Fumarate hydratase ameliorates pressure overload induced cardiac remodeling by controlling Elovl7-mediated biosynthesis of unsaturated fatty acids. Acta Pharmacologica Sinica. 47(2). 328–343. 1 indexed citations
3.
Zhang, Tong, Lanlan Li, Saiyang Xie, et al.. (2024). Matairesinol blunts adverse cardiac remodeling and heart failure induced by pressure overload by regulating Prdx1 and PI3K/AKT/FOXO1 signaling. Phytomedicine. 135. 156054–156054. 8 indexed citations
4.
Xie, Saiyang, et al.. (2024). Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future. Cell Biology and Toxicology. 40(1). 17–17. 30 indexed citations
5.
Xie, Saiyang, et al.. (2024). Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies. Biomolecules. 14(12). 1614–1614. 4 indexed citations
6.
Li, Lanlan, Saiyang Xie, & Wei Deng. (2024). RNA binding proteins: Mechanistic considerations and perspectives in controlling cardiovascular diseases. European Journal of Pharmacology. 987. 177101–177101.
7.
Xie, Saiyang, Yun Xing, Lanlan Li, et al.. (2024). Impeding Nucleotide‐Binding Oligomerization Domain‐Like Receptor 3 Inflammasome Ameliorates Cardiac Remodeling and Dysfunction in Obesity‐Associated Cardiomyopathy. Journal of the American Heart Association. 13(23). e035234–e035234. 4 indexed citations
8.
Xie, Saiyang, Yun Xing, Min Zhang, et al.. (2023). USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart. Circulation. 149(9). 684–706. 64 indexed citations
9.
Chen, Jiaojiao, Yun Xing, Shiqiang Liu, et al.. (2023). Targeting heat shock protein 47 alleviated doxorubicin-induced cardiotoxicity and remodeling in mice through suppression of the NLRP3 inflammasome. Journal of Molecular and Cellular Cardiology. 186. 81–93. 7 indexed citations
10.
Xie, Saiyang, et al.. (2023). Epicardial Adipose Tissue: a Potential Therapeutic Target for Cardiovascular Diseases. Journal of Cardiovascular Translational Research. 17(2). 322–333. 6 indexed citations
12.
Xie, Saiyang, Shiqiang Liu, Qingqing Wu, et al.. (2022). Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling. EBioMedicine. 86. 104359–104359. 25 indexed citations
13.
Xing, Yun, et al.. (2022). Targeting interleukin-21 inhibits stress overload-induced cardiac remodelling via the TIMP4/MMP9 signalling pathway. European Journal of Pharmacology. 940. 175482–175482. 9 indexed citations
14.
Xie, Saiyang, Min Zhang, Yun Xing, et al.. (2022). Long‐Term Activation of Glucagon‐like peptide‐1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes. Journal of the American Heart Association. 11(19). e026728–e026728. 24 indexed citations
15.
Liu, Chen, Tongtong Hu, Zhulan Cai, et al.. (2020). Nucleotide-Binding Oligomerization Domain-Like Receptor 3 Deficiency Attenuated Isoproterenol-Induced Cardiac Fibrosis via Reactive Oxygen Species/High Mobility Group Box 1 Protein Axis. Frontiers in Cell and Developmental Biology. 8. 713–713. 9 indexed citations
16.
Wu, Qingqing, Yang Xiao, Chen Liu, et al.. (2019). The protective effect of high mobility group protein HMGA2 in pressure overload-induced cardiac remodeling. Journal of Molecular and Cellular Cardiology. 128. 160–178. 21 indexed citations
17.
Liu, Chen, Qingqing Wu, Zhulan Cai, et al.. (2019). Zingerone attenuates aortic banding‐induced cardiac remodelling via activating the eNOS/Nrf2 pathway. Journal of Cellular and Molecular Medicine. 23(9). 6466–6478. 20 indexed citations
18.
Wu, Qingqing, Wei Deng, Xiao Yang, et al.. (2019). The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPARα. Oxidative Medicine and Cellular Longevity. 2019. 1–17. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026